Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 13 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-3.53 Insider Own3.17% Shs Outstand48.12M Perf Week14.83%
Market Cap5.07M Forward P/E- EPS next Y-1.66 Insider Trans0.00% Shs Float39.41M Perf Month-73.68%
Income- PEG- EPS next Q-0.76 Inst Own106.45% Short Float15.32% Perf Quarter-90.25%
Sales162.47M P/S0.03 EPS this Y2.60% Inst Trans- Short Ratio0.34 Perf Half Y-96.55%
Book/sh-1.05 P/B- EPS next Y50.40% ROA- Short Interest6.04M Perf Year-99.04%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range0.05 - 11.77 Perf YTD-85.93%
Dividend Est.- P/FCF- EPS past 5Y- ROI- 52W High-99.11% Beta1.05
Dividend TTM- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low108.51% ATR (14)0.11
Dividend Ex-Date- Current Ratio- EPS Y/Y TTM-12.67% Oper. Margin- RSI (14)34.60 Volatility159.10% 54.22%
Employees550 Debt/Eq- Sales Y/Y TTM20.09% Profit Margin- Recom2.50 Target Price1.67
Option/ShortNo / No LT Debt/Eq- EPS Q/Q- Payout- Rel Volume0.00 Prev Close0.11
Sales Surprise0.50% EPS Surprise-9.43% Sales Q/Q62.80% EarningsNov 06 AMC Avg Volume18.01M Price0.11
SMA20-67.36% SMA50-78.42% SMA200-96.18% Trades Volume0 Change0.00%
Date Action Analyst Rating Change Price Target Change
Nov-27-23Downgrade JP Morgan Overweight → Neutral
Nov-21-23Downgrade Robert W. Baird Outperform → Neutral
Jul-05-23Resumed JP Morgan Overweight $18
Feb-02-23Initiated UBS Buy $15
Mar-24-22Initiated Canaccord Genuity Buy $50
Jan-06-21Upgrade Cowen Market Perform → Outperform $75
Sep-09-20Initiated Morgan Stanley Equal-Weight $43
Nov-15-19Initiated Stifel Buy
Oct-09-18Initiated UBS Buy
Oct-12-17Downgrade Janney Buy → Neutral
Feb-09-24 06:30AM
Feb-05-24 11:18AM
Feb-04-24 07:45PM
Feb-01-24 06:00AM
03:00PM Loading…
Jan-07-24 03:00PM
Jan-05-24 04:01PM
Jan-04-24 06:00AM
Dec-25-23 10:14PM
Nov-19-23 06:16PM
Nov-17-23 05:22PM
Nov-16-23 12:51AM
Nov-09-23 12:00PM
Nov-07-23 10:52AM
05:30PM Loading…
Nov-06-23 05:30PM
Nov-02-23 10:00AM
Nov-01-23 05:00AM
Oct-30-23 10:00AM
Oct-10-23 12:06PM
Oct-03-23 06:00AM
Sep-19-23 01:08PM
Sep-14-23 06:00AM
Sep-13-23 06:00AM
Sep-12-23 09:48AM
06:00AM Loading…
Sep-07-23 06:00AM
Sep-05-23 06:00AM
Aug-28-23 05:53AM
Aug-23-23 12:58PM
Aug-21-23 06:00AM
Aug-08-23 05:00AM
Aug-03-23 07:00PM
Jul-11-23 05:00AM
Jul-10-23 05:00AM
Jun-30-23 04:00PM
Jun-09-23 04:00PM
Jun-08-23 07:01AM
Jun-01-23 05:54PM
May-31-23 06:00AM
May-28-23 08:12AM
May-22-23 05:00AM
May-18-23 02:57PM
May-17-23 04:17PM
May-09-23 07:43AM
May-03-23 05:25PM
Apr-12-23 06:51AM
Apr-10-23 06:00AM
Mar-08-23 04:00PM
Mar-02-23 05:21AM
Mar-01-23 05:39PM
Feb-28-23 05:15PM
Feb-23-23 06:00AM
Feb-14-23 06:00AM
Feb-06-23 06:00AM
Feb-02-23 06:00AM
Jan-19-23 06:00AM
Jan-08-23 06:00AM
Jan-03-23 06:00AM
Dec-31-22 06:14AM
Dec-22-22 06:00AM
Dec-16-22 05:35AM
Dec-13-22 12:24PM
Dec-06-22 06:00AM
Nov-13-22 07:22AM
Nov-10-22 06:00AM
Nov-09-22 06:00AM
Nov-07-22 05:25PM
Oct-19-22 07:58AM
Oct-13-22 06:00AM
Oct-12-22 06:00AM
Oct-04-22 05:13PM
Sep-07-22 06:00AM
Aug-09-22 06:00AM
Aug-08-22 12:06PM
Aug-04-22 05:35PM
Jul-28-22 10:03AM
Jul-21-22 09:55AM
Jul-11-22 06:00AM
Jun-27-22 12:27PM
Jun-06-22 06:00AM
Jun-04-22 10:38AM
NanoString Technologies, Inc. develops, manufactures, and sells technology for scientific and clinical information in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter Pro and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; panels with oncology, immunology and infectious disease, and neuroscience applications. Further, the company offers Master Kits, cartridges, ancillary reagents, tips and reagent plates to setup and process samples in instruments; and Prosigna in vitro diagnostic kits. The company is also developing GeoMx DSP system to enable the field of spatial biology. It has collaboration with Lam Research Corporation for the development of NGS sequencing platform and related assays; and Parker Institute for Cancer Immunotherapy to develop CAR-T regimens that enhances patient outcomes for various types of cancer, as well as collaboration with Stanford Medicine, Acrobat Genomics, and Illumina Accelerator to discover new drug targets for gene editing-based therapeutics. NanoString Technologies, Inc. was incorporated in 2003 and is headquartered in Seattle, Washington. On February 4, 2024, NanoString Technologies, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
YOUNG WILLIAMDirectorJun 17Option Exercise0.0014,851061,551Jun 20 04:18 PM
ROLLISON DANA E.DirectorJun 17Option Exercise0.0014,851019,268Jun 20 04:19 PM
Foy Teresa M.DirectorJun 17Option Exercise0.002,43406,275Jun 20 04:19 PM
Norden GregoryDirectorJun 17Option Exercise0.0014,851047,419Jun 20 04:19 PM
Malloy KirkDirectorJun 17Option Exercise0.0014,851024,251Jun 20 04:16 PM
GEORGE JANETDirectorJun 17Option Exercise0.0014,851019,268Jun 20 04:17 PM
GEORGE JANETDirectorJun 17Option Exercise0.0014,851019,268Jun 20 04:17 PM
FINNEY ELISHA WDirectorJun 17Option Exercise0.0014,851021,446Jun 20 04:17 PM
WAITE CHARLES P JRDirectorJun 17Option Exercise0.0014,851038,151Jun 20 04:18 PM
Bailey K ThomasChief Financial OfficerMay 26Buy5.7615,00086,44575,388May 30 08:36 AM
GRAY R BRADLEYPresident and CEOMay 25Buy5.8030,000174,000338,395May 30 08:36 AM
YOUNG WILLIAMDirectorMay 24Buy5.6935,400201,51146,700May 26 08:41 AM
Norden GregoryDirectorApr 27Option Exercise8.458,76874,09032,568Apr 28 07:22 PM
Foy Teresa M.DirectorApr 18Option Exercise0.003,84103,841Apr 26 03:20 PM
WAITE CHARLES P JRDirectorMar 13Buy8.3512,000100,20023,300Mar 14 04:41 PM
ROLLISON DANA E.DirectorMar 08Option Exercise0.001,67604,417Mar 09 04:38 PM
GEORGE JANETDirectorMar 08Option Exercise0.001,67604,417Mar 09 04:37 PM
Norden GregoryDirectorMar 07Buy9.8412,500123,00023,800Mar 08 04:08 PM
GRAY R BRADLEYPresident and CEOMar 06Option Exercise0.0050,8460318,752Mar 07 06:58 PM
Bailey K ThomasChief Financial OfficerMar 06Option Exercise0.0011,224063,709Mar 07 06:58 PM
BEECHEM JOSEPH MSVP, Research & DevelopmentMar 06Option Exercise0.0014,966098,449Mar 07 06:59 PM
Bailey K ThomasChief Financial OfficerMar 04Option Exercise0.004,989055,763Mar 07 06:58 PM